Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2007 110(11):2833-2833 - Subject
- Language
- ISSN
- 0006-4971